TELA Bio Inc.
Last updated September 27, 2026
Organization details
- Legal name
- TELA Bio Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Malvern
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TELA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001561921
- EIN
- 45-5320061
Board of directors
-
Antony Koblish · Director · Chief Executive OfficerSince 2023
-
Betty Jo Rocchio · DirectorSince 2025
-
Douglas G. Evans · DirectorSince 2023
-
Federica F. O'Brien · DirectorSince 2023
-
Guido J. Neels · DirectorSince 2026
-
Guy P. Nohra · DirectorSince 2026
-
Heather C. Getz · Director · Chief Executive OfficerSince 2026
-
Jeffrey Blizard · DirectorSince 2024
-
John Nosenzo · DirectorSince 2023
-
Joseph H. Capper · DirectorSince 2026
-
Kurt Azarbarzin · DirectorSince 2023
-
Lisa N. Colleran · DirectorSince 2023
-
Paul Thomas · DirectorSince 2026
-
Vincent J. Burgess · DirectorSince 2023
-
William J. Plovanic · DirectorSince 2025
Chief executives
Heather C. Getz
· Chief Executive Officer
Since August 2026
Antony Koblish
· Chief Executive Officer
Until August 2026
· Former
Director election results
Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.0%
-
98.9%
-
99.2%
Board connections
7 of this board's directors also sit on 8 other boards.
- via Guido J. Neels and Paul Thomas
- via Guido J. Neels and Guy P. Nohra
- via Joseph H. Capper
- via Guido J. Neels
- via Federica F. O'Brien
- via Heather C. Getz
- via Joseph H. Capper
- via Jeffrey Blizard
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $4,186,456
- 7 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | Joseph H. Capper Director | Open-market purchase | +25,000 | $1.22 | $30,530 |
| Sep 16, 2026 | Joseph H. Capper Director | Open-market purchase | +50,000 | $1.17 | $58,265 |
| Sep 15, 2026 | Joseph H. Capper Director | Open-market purchase | +50,000 | $1.06 | $52,940 |
| Sep 14, 2026 | Joseph H. Capper Director | Open-market purchase | +25,000 | $1.02 | $25,503 |
| Aug 17, 2026 | Heather C. Getz Director, Officer (Chief Executive Officer) | Open-market purchase | +12,500 | $0.66 | $8,311 |
| Aug 14, 2026 | Heather C. Getz Director, Officer (Chief Executive Officer) | Open-market purchase | +15,000 | $0.70 | $10,467 |
| Aug 3, 2026 | Heather C. Getz Director, Officer (Chief Executive Officer) | Grant or award | +500,000 | — | — |
| Jul 15, 2026 | Joseph H. Capper Director | Grant or award | +6,227 | $0.79 | $4,888 |
| Jul 15, 2026 | William J. Plovanic Director | Grant or award | +20,930 | $0.79 | $16,430 |
| Jun 9, 2026 | Betty Jo Rocchio Director | Grant or award | +11,675 | — | — |
| Jun 9, 2026 | Joseph H. Capper Director | Grant or award | +11,925 | — | — |
| Jun 9, 2026 | William J. Plovanic Director | Grant or award | +11,675 | — | — |
| Jun 9, 2026 | Guido J. Neels Director | Grant or award | +11,925 | — | — |
| Jun 9, 2026 | Paul Thomas Director | Grant or award | +11,925 | — | — |
| Jun 9, 2026 | Guy P. Nohra Director | Grant or award | +11,925 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.